In the SURMOUNT 1 trial, tirzepatide at doses of 5 mg, 10 mg and 15 mg were evaluated against placebo, with pooled tirzepatide groups resulting in significant decreases in total cholesterol, LDL-C, VLDL-C, FFA, and triglycerides and an increase in HDL-C at week 72 of follow-up [35]
13 In other words, GLP-1 medicines reduce disease complications directly and indirectly in overlapping ways, perhaps most importantly by reducing chronic inflammation
Research in animal models has clarified the dual pathway mechanism
Bydureon kept exenatide relevant as newer GLP-1 drugs emerged, but eventually exenatides role diminished since newer agents offered even greater efficacy
FDA / Federal Register
Can Vitamin B12 shots help with skin health and hydration